Skip to main content
Clinical Trials/NCT03169686
NCT03169686CompletedNot Applicable

The Efficacy of WeChat Based Interventions ('WeChat WeQuit' Program) for Smoking Cessation in China: a Randomized Trial

Sir Run Run Shaw Hospital1 site in 1 country2,000 target enrollmentStarted: March 19, 2020Last updated:
Conditions

Trial Snapshot

Phase
Not Applicable
Status
Completed
Enrollment
2,000
Locations
1
Primary Endpoint
Biochemically Validated Continuously Abstinence

Study Overview

Brief Summary

This proposed project is to assess whether WeChat-based smoking cessation interventions ('WeChat WeQuit' program) will be effective at helping people in China who smoke, to quit.

Study Design

Study Type
Interventional
Allocation
Randomized
Intervention Model
Parallel
Primary Purpose
Health Services Research
Masking
Single (Participant)

Eligibility Criteria

Ages
18 Years to — (Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
Yes

Inclusion Criteria

  • Daily Chinese cigarette smokers.
  • 18 years of age and older living.
  • Being able to read and write in Chinese.
  • Owning a smartphone and knowing how to use WeChat.
  • Willing to make an attempt to quit smoking in the next month.
  • Willing to provide informed consent to participate in the study.

Exclusion Criteria

  • Nonsmokers.
  • Smokers without attempt to quit.
  • Below 18 years old.
  • Unable to use smartphone and WeChat.
  • Unable to read and write in Chinese.

Outcomes

Primary Outcomes

Biochemically Validated Continuously Abstinence

Time Frame: 26 weeks

The primary outcome will be biochemical validation of self-reported 26-week continuous smoking abstinence

Secondary Outcomes

  • Self-reported 7-day Point Abstinence(26 weeks)
  • Self-reported Continuous Abstinence(26 weeks)

Investigators

Sponsor Class
Other
Responsible Party
Principal Investigator
Principal Investigator

Yanhui Liao

Attending Psychiatrist

Sir Run Run Shaw Hospital

Study Sites (1)

Loading locations...

Similar Trials